Can Metoprolol reduce the risk of recurrent heart attacks and what evidence supports its use in secondary cardiovascular event prevention?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Metoprolol has shown efficacy in reducing recurrent heart attacks by decreasing heart rate and blood pressure, reducing myocardial oxygen demand. Evidence includes its inclusion in guidelines by the AHA for secondary prevention.